CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) IPO
IPO
Priced at US$4.00 a share on Nov 7, 2019.
- Price
- US$4.00 a share
- Shares offered
- 2,125,000 shares of common stock
- Offering size
- US$850,000
- Underwriters' option
- Up to 318,750 more shares
- Listing
- CNSP on the Nasdaq Capital Market
- Shares delivered
- On or about Nov 13, 2019
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 28, 2019 |
| Filed publicly | Jun 28, 2019 |
| Amended 3 times | Newest Oct 7, 2019 |
| Shares registered with an exchange | Nov 5, 2019 |
| Declared effective by the SEC | Nov 7, 2019 |
| Final prospectus, with the price | Nov 8, 2019 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Nov 8, 2019 |
| EFFECT · Notice that a registration is effective | Nov 7, 2019 |
| CERT · Exchange's certificate of listing | Nov 6, 2019 |
| CORRESP · Letter to the SEC | Nov 5, 2019 |
| CORRESP · Letter to the SEC | Nov 5, 2019 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 5, 2019 |
| FWP · Free writing prospectus | Oct 15, 2019 |
| FWP · Free writing prospectus | Oct 10, 2019 |
| S-1/A · Registration statement, amended | Oct 7, 2019 |
| S-1/A · Registration statement, amended | Aug 22, 2019 |
| FWP · Free writing prospectus | Jul 16, 2019 |
| CORRESP · Letter to the SEC | Jul 16, 2019 |
| S-1/A · Registration statement, amended | Jul 16, 2019 |
| UPLOAD · Letter from the SEC | Jul 10, 2019 |
| S-1 · Registration statement | Jun 28, 2019 |
| CORRESP · Letter to the SEC | Jun 28, 2019 |
| UPLOAD · Letter from the SEC | Apr 24, 2019 |
| DRS · Draft registration statement | Mar 28, 2019 |
From the cover of the final prospectus (424B4) filed Nov 8, 2019